Many drugs affect your body’s endorphin system, either by mimicking endorphins directly, triggering their release, or blocking the receptors they bind to. Opioids like morphine and fentanyl have the most powerful effect, but alcohol, nicotine, cocaine, cannabis, and even some prescription antidepressants also interact with this system in meaningful ways. Understanding how each one works helps explain why these substances feel the way they do and why stopping them can be so difficult.
How Endorphins Work in Your Body
Endorphins are your body’s natural painkillers and mood lifters. They bind to opioid receptors, primarily a type called the mu receptor, which controls pain relief, feelings of pleasure, and physical dependence. When endorphins lock onto these receptors, they trigger a release of dopamine in your brain’s reward center (the nucleus accumbens), producing that warm, satisfied feeling you get after a hard workout or a good laugh.
Drugs that affect endorphins generally do one of three things: they pretend to be endorphins and bind to the same receptors, they cause your brain to release more of its own endorphins, or they block endorphin receptors entirely. The consequences vary enormously depending on which route a drug takes.
Opioids: The Strongest Endorphin Mimics
Morphine, heroin, fentanyl, oxycodone, and other opioids work by binding directly to the same mu receptors that your natural endorphins use. They are, in effect, synthetic endorphins, but far more potent than anything your body produces on its own. The mu-1 receptor handles pain relief, while the mu-2 receptor is responsible for the euphoria, slowed breathing, and constipation that opioids are known for.
Because opioids flood these receptors with a signal much stronger than natural endorphins provide, your brain adapts. With repeated use, your receptors either decrease in number or become less sensitive, a process called downregulation. This is the biological basis of tolerance: you need more of the drug to feel the same effect. It also means your natural endorphin system becomes less effective on its own, which is why people withdrawing from opioids experience heightened pain, anxiety, and an inability to feel pleasure from everyday activities.
Alcohol and Endorphin Release
Alcohol doesn’t bind to opioid receptors the way opioids do. Instead, drinking triggers your brain to release its own endorphins and enkephalins (a closely related group of natural opioid molecules) in reward-related brain regions. These endorphins then stimulate mu and delta opioid receptors, which in turn increase dopamine release in the nucleus accumbens. This chain reaction is a key part of why alcohol feels rewarding.
The mechanism works through a specific pathway. Normally, dopamine-producing neurons in a deep brain region called the ventral tegmental area are kept in check by inhibitory neurons. When alcohol prompts the release of beta-endorphin, those endorphins suppress the inhibitory neurons, effectively taking the brakes off dopamine production. This is one reason opioid-blocking medications are sometimes used to help people reduce heavy drinking: without the endorphin payoff, alcohol loses much of its appeal.
This endorphin response is strongest with light or acute drinking. Chronic heavy alcohol use disrupts the balance of the opioid system over time, contributing to the cycle of dependence.
Nicotine’s Modest Endorphin Bump
Smoking a cigarette does raise beta-endorphin levels, but the effect is small and inconsistent compared to other drugs. In one study, plasma beta-endorphin levels rose from about 20.5 to 27 picograms per milliliter after smoking, a statistically significant but modest increase. The researchers noted a great deal of individual variability, with some smokers showing almost no change at all.
Nicotine also increases levels of cortisol (a stress hormone) and several other hormones. The endorphin bump likely contributes to the calming, mildly pleasurable sensation smokers report, but it’s probably a secondary player compared to nicotine’s more direct effects on dopamine and acetylcholine systems.
Cocaine and the Opioid System
Cocaine is primarily a stimulant that floods the brain with dopamine, but it also has a notable relationship with endorphins. A single dose of cocaine increases beta-endorphin release in the nucleus accumbens, which likely contributes to the initial rush. Chronic cocaine use, however, activates the opioid system in more complex and sometimes opposing ways.
With repeated use, cocaine ramps up activity in another branch of the opioid system involving dynorphins, which bind to kappa opioid receptors. Unlike endorphins, dynorphins produce unpleasant, stressful feelings and reduce dopamine release. This creates a push-pull dynamic: the endorphin side drives reward and craving, while the dynorphin side drives anxiety and dysphoria. Over time, the balance tips toward discomfort, which helps explain why long-term cocaine users often feel worse during withdrawal than they did before they ever used the drug.
Post-mortem brain studies of people with a history of cocaine abuse have shown decreased levels of enkephalin activity in certain brain regions, suggesting the natural opioid system may become depleted with heavy use.
Cannabis and Endorphin Cross-Talk
THC, the primary psychoactive compound in cannabis, interacts with the endorphin system indirectly. When THC activates cannabinoid receptors, it increases levels of enkephalins in the nucleus accumbens. Repeated THC exposure also boosts the expression of genes that produce opioid peptides.
Researchers have proposed that the dual euphoric and dysphoric effects of THC (feeling relaxed and happy at lower doses, anxious or paranoid at higher ones) may actually be mediated by opposing opioid receptor activity. Mu-opioid receptor stimulation drives the pleasurable side, while kappa-opioid receptor activation drives the uncomfortable side. In this model, cannabis doesn’t just affect the endocannabinoid system in isolation; it recruits the endorphin system to produce many of its mood effects.
Antidepressants and Endorphin Genes
SSRIs and other antidepressants are designed to work on serotonin and norepinephrine, but they appear to affect the endorphin system as well. When mice are treated long-term with fluoxetine (the active ingredient in Prozac), one of the most dramatically upregulated genes is proenkephalin, the gene responsible for producing enkephalins. This suggests that part of how antidepressants relieve depression may involve boosting the body’s natural opioid signaling over time.
This connection is still being mapped out, but it adds an interesting layer to our understanding of depression itself. If the endorphin system plays a significant role in depressive disorders, it may help explain why some people respond well to antidepressants while others don’t: the underlying opioid dysfunction may vary from person to person.
Drugs That Block Endorphins
Not all drugs that affect endorphins increase their activity. Naltrexone and naloxone are opioid receptor antagonists, meaning they sit on the same receptors endorphins use but don’t activate them. They essentially lock endorphins out.
This blocking effect has practical applications. Naltrexone is used to treat both opioid addiction and alcohol use disorder, because it removes the endorphin-driven reward from using those substances. In a telling study, participants in a high-intensity aerobics class who were given naltrexone before exercising did not experience the positive mood shift that the placebo group did. The “runner’s high” simply didn’t happen, providing strong evidence that exercise-induced mood improvements are driven by endorphins acting on opioid receptors.
How the Endorphin System Recovers
When drugs repeatedly overstimulate or block opioid receptors, the system adapts by reducing the number of available receptors or dialing down their sensitivity. This downregulation depends on the drug, the dose, and how long you’ve been using it. The result is that your natural endorphin system becomes less responsive, which is why the early stages of sobriety often involve heightened pain sensitivity, low mood, and difficulty finding pleasure in normal activities.
The good news is that these changes are not permanent. Brain imaging studies show that gray matter volume and chemical balances can begin to normalize within six months to a year of sustained sobriety. The timeline varies, and some people recover faster than others, but the brain does have a remarkable capacity to recalibrate its endorphin system once the external chemical pressure is removed.
Exercise as a Natural Comparison
Exercise reliably increases beta-endorphin levels, though the magnitude is far smaller than what opioid drugs produce. This is actually part of what makes exercise-induced endorphins safer: they stimulate the reward system enough to improve mood without triggering the dramatic receptor downregulation that comes with drug use. Interestingly, prolonged exercise training over weeks and months may actually decrease the beta-endorphin spike from any single workout, suggesting the body adapts to this natural stimulus as well, though in a much gentler way.
Anabolic steroids provide an unusual case study here. Active steroid users show significantly higher beta-endorphin levels than both non-users and people who recently stopped using steroids. Those elevated endorphin levels correlated with higher motivation to exercise, hinting that part of what makes steroids psychologically reinforcing is their effect on the opioid system rather than just muscle growth.